ELTP — Elite Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapContrarian

Annual balance sheet for Elite Pharmaceuticals, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	8.54	7.83	7.11	11.3	29.8
Net Total Accounts Receivable
Net Total Receivables	3.06	3.09	19.5	29.2	59.7
Total Inventory
Prepaid Expenses
Total Current Assets	18.9	21.5	40	57.7	112
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.98	10.4	14.6	14.1	13
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	35.1	40.9	83.7	96.4	138
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6.69	7.83	13	11.8	17.4
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	9.93	11.9	26.1	42.9	39.4
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	25.2	29	57.6	53.5	98.9
Total Liabilities & Shareholders' Equity	35.1	40.9	83.7	96.4	138
Total Common Shares Outstanding